Preparing for China · patient guide

Infusion therapy review in China: what to expect

An infusion therapy review in China is a records-based assessment by a treating hospital specialist of whether intravenous treatment is appropriate for you, which regimen and monitoring it would need, and whether it can be delivered safely alongside your existing care. It is not a booking for a specific drug. The hospital decides suitability, and the written plan and fee scope must be confirmed before you travel.

Go to the practical guidance ↓
AI illustration: Three adults having a discussion at a table with folders and a notebook in a home or office setting.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What an infusion therapy review actually assesses

"Infusion therapy" describes medicines or fluids given through a vein rather than by mouth. That covers a wide range: iron for anaemia, biological drugs for inflammatory or autoimmune disease, chemotherapy and supportive cancer treatment, antibiotics, immune globulin, nutrition support and other specialist infusions. Because the range is so broad, a useful review starts with the exact medicine or treatment category you are asking about, not with the word "infusion".

The reviewing specialist is being asked several separate questions. Is intravenous delivery the right route for your condition, or would an oral or subcutaneous option be equally effective and easier to manage? If intravenous treatment is appropriate, which regimen, dose and interval apply to you? What monitoring is needed before, during and after each infusion? And can that monitoring be arranged around your travel and your care at home?

A review is also a check on safety. Some infusions require pre-treatment blood tests, allergy checks, heart monitoring or observation for a set period afterwards. Others interact with medicines you already take. The specialist needs your current medication list, not only the drug you hope to receive.

Expect the output to be an opinion and a proposed plan, not a guarantee. A records-based review cannot confirm final suitability, because the treating team will want to assess you in person, repeat or review tests, and confirm that the medicine and monitoring are available for your case. Those confirmations belong to the hospital.

The records that make a review useful

The quality of a review depends heavily on what the specialist can see. A short summary of your diagnosis and question helps, but the clinical detail does the work. Ask your current treating team which documents they would want another specialist to read before commenting on your treatment.

For most infusion questions, the relevant file includes the confirmed diagnosis and how it was established, the treatment history with drug names, doses, dates and responses, and the reason a change or continuation is being considered. Recent blood results, imaging reports and any allergy or adverse-reaction records matter. So does a complete current medication list, including over-the-counter products and supplements, because interactions are part of the assessment.

If you have already received the infusion elsewhere, the administration records are valuable: the regimen, the number of cycles or doses completed, and any reactions during or after infusion. If the question is about continuing treatment in China, the specialist also needs to know your intended length of stay and what follow-up you have arranged at home.

You do not need to send a complete archive at first contact. A brief summary of the diagnosis and your main question is enough to start, and the team can then explain which records are relevant. Avoid sending passport numbers, payment details or unrelated personal documents through an enquiry form.

Questions to put to the treating team before you commit

A productive review ends with answers you can act on. Prepare your questions in advance and ask them of the hospital specialist, not only of a coordinator. The clinical answers must come from the treating team.

Start with the treatment itself: is intravenous delivery necessary for my condition, and what alternatives exist? If a specific drug is proposed, is it approved and available for my case at this hospital, and what would happen if it were not? Ask what monitoring the regimen requires and whether that monitoring can be completed within your planned stay.

Then ask about continuity. What records will the hospital need from my home team, and what will it send back? If treatment continues after I return home, who will supervise it there? These questions matter because an infusion given once is rarely the whole plan; the review should address the course, not a single session.

Finally, ask what the review can and cannot establish. A records-based opinion may support a proposed plan, but it does not replace an in-person assessment, and it does not by itself secure hospital acceptance or confirm that a particular therapy will be offered. Ask the hospital directly what its acceptance process involves for your case.

Safety, supervision and what happens during treatment

Infusion reactions can occur with many intravenous medicines, ranging from mild to serious. This is why infusions are given in a supervised setting with staff trained to recognise and respond to reactions, and why some regimens require observation afterwards. Ask the treating team what monitoring applies to your specific medicine and what you should do if you feel unwell after leaving the hospital.

Tell the team about previous reactions to any medicine, even mild ones, and about allergies, kidney or liver problems, pregnancy or breastfeeding, and any condition that affects how you handle fluids. These details change both the choice of treatment and the supervision it needs.

Do not stop or change prescribed medicines on your own in preparation for a review. If your current treatment is controlling your condition, that context belongs in the discussion. Any decision to pause, switch or combine treatments is a clinical one for your prescribing doctors, who should be told about your plans for care in China.

If your symptoms worsen or you become unwell, local urgent assessment takes priority over travel planning. An overseas review is not a route for emergency care.

Costs, coordination and what to confirm in writing

Infusion treatment involves several kinds of cost, and they should not be treated as one number. The hospital's charges for the medicine, the infusion itself, any pre-treatment tests and monitoring, and the facility where it is given are set by the hospital. Our coordination and interpretation services are separate and are agreed with you directly.

Because infusion regimens differ so much, a meaningful estimate depends on the exact medicine, dose, number of sessions and monitoring plan. Ask the hospital for a written quote that states what it covers and what it does not, including whether tests, observation time and take-home medicines are part of it. Do not assume that a quoted figure includes everything, and do not assume it excludes a particular item either; the written scope is the answer.

If you would like help with the practical side, ChinaSpecialistCare can support specialist matching and appointment coordination, and separately agreed hospital companion and interpretation. These are non-clinical services. They do not decide whether treatment is suitable, and they do not replace the hospital's own assessment or fees.

Practical preparation and the next step

Once a hospital has indicated that a review is possible, prepare a concise file: the diagnosis, treatment history, recent results, medication list and your specific question. Keep a copy of everything you send, and note who at the hospital is handling your case. If you need interpretation during appointments, arrange it in advance so that consent and safety discussions are not rushed.

Ask the hospital what it needs from you before any appointment is confirmed, and ask which parts of the plan are provisional until you are assessed in person. Confirm the practical arrangements, including how many visits the plan may involve and how results will be shared with your home team, rather than assuming a single trip covers everything.

An initial enquiry with ChinaSpecialistCare is free and does not require buying a proxy consultation. You can start with a brief summary of your diagnosis and question, and the team will explain what information would help and what the relevant next step is. The hospital makes the clinical decisions and decides whether to accept your case.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. payment

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.